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Apoptosis induction is an important host defense mechanism to control viral infection, which is antagonized by viral proteins.
Murine cytomegalovirus m41.1 encodes a viral inhibitor of BAK oligomerization (vIBO) that blocks the mitochondrial apoptosis
mediator BAK. However, its importance for viral fitness in vivo has not been investigated. Here, we show that an m41.1-deficient
virus attains reduced titers in salivary glands of wild-type but not Bak1/mice, indicating a requirement of BAK inhibition for
optimal dissemination in vivo.
Programmed cell death is thought to function as an innate an-tiviral defense mechanism. This hypothesis is supported by
the fact that many viruses have evolved cell death-inhibiting pro-
teins (1). However, in only a few instances has the importance of
these proteins for viral fitness been determined in vivo (2–6). Mu-
rine cytomegalovirus (MCMV), a betaherpesvirus, has a pro-
tracted replication cycle and causes persistent infections in its
host. MCMV expresses several cell death inhibitors, which are
presumably needed to keep the host cell alive and promote viral
replication and dissemination (7, 8). SinceMCMV’s natural host,
the mouse, is an easily available and genetically manipulable or-
ganism, the MCMV-infected mouse model can serve as an excel-
lent system to study the in vivo relevance of different cell death
pathways.
InMCMV-infected cells, the extrinsic, death receptor-induced
apoptosis pathway is blocked by the MCMV protein M36, which
inhibits caspase-8 activation (9). An MCMV M36 mutant was
strongly attenuated in vitro and in vivo (2). MCMVs carrying mu-
tations in M45 showed an even stronger attenuation in vivo with
barely detectable organ titers (5, 10). The viralM45 protein inhib-
its both death receptor-induced and virus-induced programmed
necrosis by interacting with receptor-interacting protein 1 (RIP1)
and RIP3 (11, 12). The in vivo attenuation of an M45 mutant
MCMV was abrogated in RIP3-deficient mice, which elegantly
confirmed the importance of RIP3-dependent necrosis as a host
defense mechanism (10).
Apoptosis can also be induced by different intracellular stress
signals via the intrinsic mitochondrial pathway (13). These stress
signals activate the proapoptotic Bcl-2 family members BAX and
BAK. Activated BAX and BAK oligomerize within the outer mito-
chondrial membrane and increase membrane permeability, re-
sulting in the release of cytochrome c and other proapoptotic fac-
tors into the cytosol. Cytochrome c then induces the formation of
a so-called apoptosome complex and subsequent activation of
caspases (13). MCMV inhibits the intrinsic apoptosis pathway at
mitochondria with two separate viral proteins: a BAX-specific in-
hibitor, encoded by open reading frame (ORF) m38.5 (14–17),
and a BAK-specific inhibitor, encoded by ORF m41.1 (18). The
mitochondrion-localized m41.1 protein is expressed from the
m41 locus and functions as viral inhibitor of BAKoligomerization
(18). In this study, we investigated the role of m41.1/viral inhibi-
tor of BAK oligomerization (vIBO) for MCMV replication and
dissemination in mice.
Since the previously constructed m41.1 mutants (18) were
not suitable for in vivo infection experiments, we constructed a
new m41.1 knockout (m41.1ko) virus and a corresponding re-
vertant. Mutagenesis was done by homologous recombination
using the bacterial artificial chromosome (BAC) clone of
MCMV strain K181 (19). First, the viral m157 gene was deleted
by replacing it with a zeocin resistance (zeo) marker, as de-
scribed previously (20) (Fig. 1A). This deletion was necessary
in order to infect C57BL/6 mice, which are resistant to MCMV
infection due to expression of the NK cell receptor Ly49H (21–
24). Resistance can be overcome by removal of m157, which
encodes a Ly49H ligand (20). In this m157 wild-type-like
(wt-l) virus genome, the m41 locus was first replaced by a galK-
kan cassette using kanamycin for positive selection. Using
2-deoxy-galactose for negative selection, galK-kan was then re-
placed by an m41 sequence in which all three m41.1 ATG
codons were mutated to ACG, leaving the protein sequence of
the overlapping m41 ORF unchanged (18). Using the same
two-step replacement strategy (which is described in detail
elsewhere [25]), the revertant (rev) was constructed (Fig. 1A).
All BACs were analyzed by restriction digestion with XbaI (Fig.
1B), as well as SnaBI and ScaI (not shown), and the entire m41
locus was sequenced to ensure that only the intended changes
were introduced (Fig. 1C). Recombinant viruses were reconsti-
tuted by transfecting BAC DNA into 10.1 fibroblasts (26) using
Polyfect transfection reagent (Qiagen). Viral DNA was purified
from virions as described previously (27) and analyzed by re-
striction digestion. The restriction patterns of the wt-l,
m41.1ko, and rev viruses were as predicted (data not shown).
To verify that m41.1 was knocked out and expression of the
unrelated m41 protein had remained unchanged, lysates of in-
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fected cells were analyzed for m41 expression by immunoblot-
ting using them41-specific antibody 2A6 and form41.1 expres-
sion by reverse transcription (RT)-PCR (Fig. 1D and E).
Before using the newly constructed K181-derived viruses
for in vivo experiments, we functionally characterized them in
cell culture-based assays. First we infected 10.1 fibroblasts at a
multiplicity of infection (MOI) of 5. Six hours postinfection
(hpi), cells were stimulated with 200 nM staurosporine (STS)
(Sigma) to induce apoptosis. Cell viability was measured 24 hpi
by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulphophenyl)-2H-tetrazolium] assay (CellTiter
96 AQueous cell proliferation assay; Promega). As shown in Fig.
2A, cells infected with the m41.1ko virus were more sensitive to
STS-induced apoptosis than the parental wt-l or rev viruses.
Next we infected RAW264.7 macrophages (ATCC TIB-71),
which are more sensitive than fibroblasts to infection-induced
proapoptotic stress. Two days postinfection (dpi), macro-
phages infected with m41.1ko virus showed clearly reduced
viability compared to cells infected with the control viruses
(Fig. 2B). To confirm that the observed phenotype was BAK
dependent, BAK and BAX knockout cells (28) were infected for
72 h. Cell viability was then analyzed by MTS assay. As shown
in Fig. 2C and D, BAK deficiency but not BAX deficiency com-
pensated for the loss of m41.1. Infection of 10.1 cells with
m41.1ko resulted in caspase-3 activation (Fig. 2E), confirming
that m41.1 is required for apoptosis inhibition. In addition, the
replication kinetics of the three viruses were determined on
10.1 fibroblasts and RAW264.7 macrophages. Replication of
the m41.1ko virus was indistinguishable from that of the con-
trol viruses in 10.1 fibroblasts but significantly reduced in mac-
rophages (Fig. 3A and B), consistent with previously published
results (18). The m41.1ko virus also replicated to lower titers in
primary bone marrow-derived macrophages (BMDMs) of
C57BL/6J but not BAK-deficient mice (B6.129-Bak1tm1Thsn/J)
(29) mice, indicating that the replication defect is BAK depen-
dent (Fig. 3C and D).
Manzur and colleagues showed that the viral BAX inhibitor
m38.5 is important for MCMV replication and dissemination in
FIG1 Construction and genetic analysis ofmutantMCMVs. (A) Them157 genewas replaced by a zeomarkerwithin theMCMVK181BAC to facilitate infection
of C57BL/6 mice. This K181m157 virus was used as a wild-type-like (wt-l) virus in all experiments. To generate an m41.1ko virus, the m41 locus was first
replaced by galK-kan followed by reinsertion of a mutated m41 ORF, in which the three ATGs of m41.1 had been changed to ACG. The revertant virus was
constructed using the same two-step strategy. (B) BACDNAofwt andmutantMCMVgenomeswas digested to check form157 deletionwith XbaI and separated
on 0.6% agarose gels. A 4.4-kb fragment in the parental K181 BAC is indicated by an arrowhead. (C) Sequencing of wt-l, m41.1ko, and rev BACDNA. In the wt-l
sequence, ATG is highlighted in boldface. Point mutations within the m41.1 ATG codons are indicated in gray. Translated amino acid sequences are shown
beneath the nucleotide sequences. (D) 10.1 fibroblasts were infected with wt-l, m41.1ko, and rev viruses. At 24 hpi, m41.1 expression was analyzed by RT-PCR
using a forward primer that ends on the T of the second m41.1 ATG codon (5=-ATGATCGTCGCGGCGAT-3= and 5=-GGAGGGCGCGACGAAAG-3=).
GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (E) Expression of m41 was analyzed by immunoblotting in virus-infected RAW264.7 macrophages using
the m41-specific antibody 2A6 (18).
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mice (16). Therefore, we wanted to analyze if BAK inhibition by
m41.1 is also of importance for viral replication and spread. To do
this, we infected 8- to 10-week-old C57BL/6J and Bak1/ mice
with 2 105 PFU of wt-l, m41.1ko, or rev virus intravenously or
intraperitoneally (Fig. 4A to E).Micewere sacrificed on days 3 and
14 after intraperitoneal infection and, due to a faster viral dissem-
ination, on days 3 and 10 after intravenous infection. Spleen, sal-
ivary gland (SG), and lung titers were determined by plaque assay.
On day 3 postinfection, viral titers in the spleen did not differ
significantly independent of the mouse strain used (Fig. 4A and
D). However, the m41.1ko strain reached moderately (10- to 50-
fold) but significantly reduced SG titers compared to wt-l and rev
viruses in C57BL/6Jmice (Fig. 4B and E). InBak1/mice, the SG
titers were similar for all three viruses, providing strong support
for the notion that BAK inhibition is necessary for optimal repli-
cation and dissemination to SGs. The m41.1ko virus also reached
lower titers in lungs of C57BL/6J mice (Fig. 4C), although lung
titers generally showed more variability. To rule out that a spon-
taneous reversion was responsible for the modest attenuation of
m41.1ko viruses in vivo, we sequenced the m41 locus of m41.1ko
viruses isolated from SGs and lungs of C57BL/6J mice. All se-
quenced isolates carried the mutant m41.1 sequence (data not
shown).
Previous studies with MCMV M36 and M45 mutants
have demonstrated a severely attenuated phenotype of these
viruses in vivo (2, 5). In contrast, MCMV mutants with an
inactivated m38.5 (16) or m41.1 (this study) gene were only
modestly attenuated in mice, reaching about 10- to 100-fold-
lower SG titers. As these organs are important for MCMV per-
sistence and transmission, even a modest attenuation is likely
to be of biological importance. One should also keep in mind
that the m38.5 and m41.1 gene products target two related
proapoptotic mitochondrial proteins, BAX and BAK, that have
been proposed to act in a largely redundant fashion (30). In
fact, an m38.5 m41.1 double-knockout (dko) virus has shown a
more prominent phenotype in cultured cells than the single-
gene knockouts (18). Hence it might be necessary to test a dko
virus in the mouse to fully appreciate the role of the intrinsic,
mitochondrially mediated apoptosis pathway as an antiviral
defense mechanism. However, MCMV with its highly specific
inhibitors offers the unique opportunity to study the contribu-
tions of BAX and BAK to infection control individually.
FIG 2 Characterization of mutant MCMVs in cell culture. (A) 10.1 fibro-
blasts were infected with wt-l, m41.1ko, and rev viruses at an MOI of 5. Six
hours postinfection, cells were stimulated with staurosporine (STS). Cell
viability was analyzed by MTS assay at 24 hpi. (B) RAW264.7 macrophages
were infected with the indicated viruses (MOI of 5). Cell viability was
measured 48 hpi by MTS assay. (C and D) Bak- or Bax-deficient mouse
embryonic fibroblasts (MEFs) were infected with wt-l, m41.1ko, or rev.
Cell viability was determined 72 hpi. Experiments were done with 5 or
more replicates; means and standard errors of the means (SEM) are shown.
Statistical significance was assessed by Student’s t test (***, P  0.001; ns,
not significant). (E) 10.1 fibroblasts were infected with wt-l, m41.1ko, and
rev virus or treated with STS to induce apoptosis. At 21 hpi, caspase-3
cleavage was analyzed by immunoblotting using a capase-3 (Casp-3)-spe-
cific antibody (no. 9662; Cell Signaling). IE1 was detected as an infection
control and -actin as a loading control using monoclonal antibodies
(MAbs) CROMA101 and Ac-74 (Sigma), respectively.
FIG 3 Replication of mutant MCMVs in cell culture. (A and B) 10.1 fibro-
blasts or RAW264.7 macrophages were infected with wt-l, m41.1ko, or rev
virus at an MOI of 0.02. Supernatants were collected, and viral titers were
determined by plaque assay or the TCID50 method. (C and D) BMDMs
were isolated as described previously (31). On day 7 after isolation, cells
were infected with wt-l, m41.1ko, or rev virus at an MOI of 0.02. Superna-
tants were collected and viral titers were determined by plaque assay. All
experiments were done in duplicate or triplicate; means and SEM are
shown.
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